{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1868","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1866","results":[{"created":"2020-04-12T13:59:00.533652+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TRAF3 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TRAF3","entity_type":"gene"},{"created":"2020-04-12T13:58:36.773030+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TRAF3 as Red List (low evidence)","entity_name":"TRAF3","entity_type":"gene"},{"created":"2020-04-12T13:58:36.764423+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: traf3 has been classified as Red List (Low Evidence).","entity_name":"TRAF3","entity_type":"gene"},{"created":"2020-04-12T13:56:58.682953+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TRAF3: Rating: RED; Mode of pathogenicity: None; Publications: 20832341; Phenotypes: {?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, MIM# 614849; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TRAF3","entity_type":"gene"},{"created":"2020-04-12T13:46:58.109783+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TPP1 as ready","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:46:58.096056+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tpp1 has been classified as Red List (Low Evidence).","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:46:55.584961+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TPP1 were changed from  to Hoyeraal-Hreidarsson syndrome","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:46:32.373582+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.151","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TPP1 were set to ","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:46:06.397724+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.150","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TPP1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:45:42.999639+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TPP1 as Red List (low evidence)","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:45:42.986634+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tpp1 has been classified as Red List (Low Evidence).","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:45:13.150215+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TPP1: Rating: RED; Mode of pathogenicity: None; Publications: 25233904; Phenotypes: Hoyeraal-Hreidarsson syndrome; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TPP1","entity_type":"gene"},{"created":"2020-04-12T13:38:20.833065+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2161","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFSF12 as ready","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:38:20.823983+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2161","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfsf12 has been classified as Red List (Low Evidence).","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:38:10.441945+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2161","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFSF12 were changed from  to Recurrent infections, poor antibody responses, decreased immunoglobulins","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:37:49.478837+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2160","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFSF12 were set to ","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:37:27.511539+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2159","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFSF12 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:37:10.094229+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2158","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TNFSF12 as Red List (low evidence)","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:37:10.080659+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2158","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfsf12 has been classified as Red List (Low Evidence).","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:36:50.650191+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2157","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFSF12: Rating: RED; Mode of pathogenicity: None; Publications: 23493554; Phenotypes: Recurrent infections, poor antibody responses, decreased immunoglobulins; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:36:04.432192+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFSF12 as ready","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:36:04.422663+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfsf12 has been classified as Red List (Low Evidence).","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:36:00.324012+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFSF12 were changed from  to Recurrent infections, poor antibody responses, decreased immunoglobulins","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:35:30.426464+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFSF12 were set to ","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:34:59.062572+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFSF12 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:34:35.605532+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.54","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TNFSF12 as Red List (low evidence)","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:34:35.596204+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.54","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfsf12 has been classified as Red List (Low Evidence).","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:34:06.079035+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFSF12: Rating: RED; Mode of pathogenicity: None; Publications: 23493554; Phenotypes: Recurrent infections, poor antibody responses, decreased immunoglobulins; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TNFSF12","entity_type":"gene"},{"created":"2020-04-12T13:19:46.318620+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2157","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFRSF4 as ready","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:19:46.309322+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2157","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf4 has been classified as Red List (Low Evidence).","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:19:38.731518+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2157","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFRSF4 were changed from  to Immunodeficiency 16, MIM# 615593","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:19:18.321245+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2156","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFRSF4 were set to ","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:18:31.792420+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2155","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFRSF4 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:18:12.340150+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2154","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TNFRSF4 as Red List (low evidence)","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:18:12.327125+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2154","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf4 has been classified as Red List (Low Evidence).","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:17:26.765156+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2153","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFRSF4: Rating: RED; Mode of pathogenicity: None; Publications: 23897980; Phenotypes: Immunodeficiency 16, MIM# 615593; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:16:52.102038+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: TNFRSF4: Changed phenotypes: Immunodeficiency 16, MIM# 615593","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:16:14.018285+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFRSF4 as ready","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:16:13.995799+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf4 has been classified as Red List (Low Evidence).","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:15:48.041460+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFRSF4 were changed from  to Immunodeficiency 16, MIM# 615593","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:15:13.533288+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.147","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFRSF4 were set to ","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:14:49.278909+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFRSF4 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:14:14.774949+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TNFRSF4 as Red List (low evidence)","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:14:14.766021+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf4 has been classified as Red List (Low Evidence).","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T13:13:44.026781+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFRSF4: Rating: RED; Mode of pathogenicity: None; Publications: 23897980; Phenotypes: Immunodeficiency, MIM# 16; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF4","entity_type":"gene"},{"created":"2020-04-12T12:41:16.857501+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2153","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFRSF13C as ready","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:41:16.849069+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2153","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf13c has been classified as Amber List (Moderate Evidence).","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:40:42.969110+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2153","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFRSF13C were changed from  to Immunodeficiency, common variable, 4, MIM# 613494","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:40:21.336130+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2152","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFRSF13C were set to ","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:40:00.932107+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2151","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFRSF13C was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:39:39.773983+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2150","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TNFRSF13C as Amber List (moderate evidence)","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:39:39.760983+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2150","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf13c has been classified as Amber List (Moderate Evidence).","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:39:21.534626+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2149","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFRSF13C: Rating: AMBER; Mode of pathogenicity: None; Publications: 19666484, 26613719; Phenotypes: Immunodeficiency, common variable, 4, MIM# 613494; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:38:40.024003+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFRSF13C as ready","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:38:40.009342+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf13c has been classified as Amber List (Moderate Evidence).","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:38:36.885645+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFRSF13C were changed from  to Immunodeficiency, common variable, 4, MIM# 613494","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:38:13.327103+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFRSF13C were set to ","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:37:43.322557+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFRSF13C was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:37:16.460960+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.50","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TNFRSF13C as Amber List (moderate evidence)","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:37:16.452119+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.50","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf13c has been classified as Amber List (Moderate Evidence).","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:36:46.424289+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFRSF13C: Rating: AMBER; Mode of pathogenicity: None; Publications: 19666484, 26613719; Phenotypes: Immunodeficiency, common variable, 4, MIM# 613494; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TNFRSF13C","entity_type":"gene"},{"created":"2020-04-12T12:36:43.140203+10:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.322","user_name":"Kristin Rigbye","item_type":"entity","text":"reviewed gene: NDUFS4: Rating: GREEN; Mode of pathogenicity: None; Publications: 10944442, 27079373, 19107570, 12616398; Phenotypes: Mitochondrial complex I deficiency, nuclear type 1, 252010, Leigh syndrome; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NDUFS4","entity_type":"gene"},{"created":"2020-04-12T12:20:17.767380+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2149","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFRSF13B as ready","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T12:20:17.758694+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2149","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf13b has been classified as Green List (High Evidence).","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T12:20:05.638111+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2149","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFRSF13B were changed from  to Immunodeficiency, common variable, 2, MIM# 240500","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T12:19:46.608878+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2148","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFRSF13B were set to ","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:48:56.500674+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2147","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFRSF13B was changed from Unknown to Other","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:48:28.061808+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2146","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFRSF13B: Rating: GREEN; Mode of pathogenicity: None; Publications: 17392798, 16007086, 18981294, 16007087; Phenotypes: Immunodeficiency, common variable, 2, MIM# 240500; Mode of inheritance: Other","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:44:01.054088+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TNFRSF13B as ready","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:44:01.045239+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tnfrsf13b has been classified as Green List (High Evidence).","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:43:58.140868+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TNFRSF13B were changed from  to Immunodeficiency, common variable, 2, MIM# 240500","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:43:27.958739+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.48","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TNFRSF13B were set to ","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:42:55.920346+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TNFRSF13B was changed from Unknown to Other","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T11:42:25.282567+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TNFRSF13B: Rating: GREEN; Mode of pathogenicity: None; Publications: 17392798, 16007086, 18981294, 16007087; Phenotypes: Immunodeficiency, common variable, 2, MIM# 240500; Mode of inheritance: Other","entity_name":"TNFRSF13B","entity_type":"gene"},{"created":"2020-04-12T09:06:52.433390+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TINF2 as ready","entity_name":"TINF2","entity_type":"gene"},{"created":"2020-04-12T09:06:52.419942+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tinf2 has been classified as Amber List (Moderate Evidence).","entity_name":"TINF2","entity_type":"gene"},{"created":"2020-04-12T09:06:35.764615+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TINF2 were changed from  to Dyskeratosis congenita, autosomal dominant 3, MIM# 613990; Revesz syndrome, MIM# 268130","entity_name":"TINF2","entity_type":"gene"},{"created":"2020-04-12T09:05:57.186904+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.143","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TINF2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TINF2","entity_type":"gene"},{"created":"2020-04-12T09:05:27.855772+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TINF2 as Amber List (moderate evidence)","entity_name":"TINF2","entity_type":"gene"},{"created":"2020-04-12T09:05:27.847146+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tinf2 has been classified as Amber List (Moderate Evidence).","entity_name":"TINF2","entity_type":"gene"},{"created":"2020-04-12T09:04:58.935492+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.141","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TINF2: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Dyskeratosis congenita, autosomal dominant 3, MIM# 613990, Revesz syndrome, MIM# 268130; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TINF2","entity_type":"gene"},{"created":"2020-04-12T09:00:23.496771+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2146","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: THBD as ready","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T09:00:23.483677+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2146","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: thbd has been classified as Amber List (Moderate Evidence).","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T09:00:15.222283+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2146","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: THBD were changed from  to {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, MIM# 612926","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:59:54.113150+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2145","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: THBD were set to ","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:59:31.320003+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2144","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: THBD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:58:57.760249+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2143","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: THBD as Amber List (moderate evidence)","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:58:57.747098+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2143","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: thbd has been classified as Amber List (Moderate Evidence).","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:58:38.934123+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2142","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: THBD: Rating: AMBER; Mode of pathogenicity: None; Publications: 29500241, 19625716; Phenotypes: {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, MIM# 612926; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:57:42.186515+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: THBD as ready","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:57:42.177227+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: thbd has been classified as Red List (Low Evidence).","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:57:38.896573+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: THBD were changed from  to {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, MIM# 612926","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:57:08.532220+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: THBD were set to ","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:56:37.940419+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: THBD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:56:09.303161+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: THBD as Red List (low evidence)","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:56:09.289797+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: thbd has been classified as Red List (Low Evidence).","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:55:34.772659+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: THBD: Rating: RED; Mode of pathogenicity: None; Publications: 29500241, 19625716; Phenotypes: {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, MIM# 612926; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"THBD","entity_type":"gene"},{"created":"2020-04-12T08:53:20.369840+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2142","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TAPBP as ready","entity_name":"TAPBP","entity_type":"gene"},{"created":"2020-04-12T08:53:20.355591+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2142","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tapbp has been classified as Red List (Low Evidence).","entity_name":"TAPBP","entity_type":"gene"},{"created":"2020-04-12T08:53:12.012853+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2142","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TAPBP were changed from  to Bare lymphocyte syndrome, type I, MIM# 604571","entity_name":"TAPBP","entity_type":"gene"}]}